Exelixis, Inc. (EXEL)
54.57
+0.49
(+0.91%)
USD |
NASDAQ |
Aug 24, 16:00
54.57
0.00 (0.00%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly) : 1.844B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.844B |
| March 31, 2026 | 1.936B |
| December 31, 2025 | 2.161B |
| September 30, 2025 | 2.161B |
| June 30, 2025 | 2.034B |
| March 31, 2025 | 2.131B |
| December 31, 2024 | 2.244B |
| September 30, 2024 | 2.275B |
| June 30, 2024 | 2.120B |
| March 31, 2024 | 2.128B |
| December 31, 2023 | 2.264B |
| September 30, 2023 | 2.348B |
| June 30, 2023 | 2.528B |
| March 31, 2023 | 2.555B |
| December 31, 2022 | 2.488B |
| September 30, 2022 | 2.491B |
| June 30, 2022 | 2.391B |
| March 31, 2022 | 2.294B |
| December 31, 2021 | 2.211B |
| September 30, 2021 | 2.112B |
| June 30, 2021 | 2.043B |
| March 31, 2021 | 1.911B |
| December 31, 2020 | 1.879B |
| September 30, 2020 | 1.852B |
| June 30, 2020 | 1.833B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.748B |
| December 31, 2019 | 1.686B |
| September 30, 2019 | 1.604B |
| June 30, 2019 | 1.489B |
| March 31, 2019 | 1.385B |
| December 31, 2018 | 1.287B |
| September 30, 2018 | 915.97M |
| June 30, 2018 | 774.97M |
| March 31, 2018 | 669.77M |
| December 31, 2017 | 284.96M |
| September 30, 2017 | 238.72M |
| June 30, 2017 | 148.51M |
| March 31, 2017 | 119.75M |
| December 31, 2016 | 89.32M |
| September 30, 2016 | 32.02M |
| June 30, 2016 | -186.13M |
| March 31, 2016 | -155.95M |
| December 31, 2015 | -140.81M |
| September 30, 2015 | -74.23M |
| June 30, 2015 | -188.19M |
| March 31, 2015 | -146.76M |
| December 31, 2014 | -114.83M |
| September 30, 2014 | -58.51M |
| June 30, 2014 | 3.243M |
| March 31, 2014 | 71.48M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | 341.40M |
| Madrigal Pharmaceuticals, Inc. | 523.72M |
| United Therapeutics Corp. | 6.400B |
| AbbVie, Inc. | -5.935B |
| Tonix Pharmaceuticals Holding Corp. | 222.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.494B |
| Total Liabilities (Quarterly) | 650.47M |
| Debt to Equity Ratio | 0.09 |
| Current Ratio | 3.456 |
| Net Debt Paydown Yield | 0.03% |